SEVA-108

N/A

Report date: 2025/05/14 15:50:11

Base Information

Drug NameSEVA-108
Drug Alias NameSEVA-108
ClassificationSmall molecules > Synthetic peptideCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionChaperonins modulators
TargetsChaperonins
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of FloridaSeva Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeva Therapeutics IncUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A